Blue Sail Medical Co (002382) Fair Value & Analysis
Healthcare · CN · Market cap 5.5B CNY
Fair value as of: Jul 22, 2026
From 4 valuation models · updated today
Fair value updated Jul 22, 2026, revised from ¥32.00 to ¥4.42 (−86.2%) since Jun 25, 2026. Share price +1.4% over the past month.
Price vs Fair Value (12 months)
12‑month range ¥5.08 – ¥8.66 · fair‑value band ¥3.01 – ¥5.82 · the ¥5.68 price screens above the ¥4.42 fair value. As of Jul 22, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Blue Sail Medical Co (002382) currently trades at ¥5.68, while our model-based Fair Value estimate is ¥4.42, implying the stock looks roughly 22.2% overvalued today. We read business quality at 43/100 (below-average quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: low).
Over the trailing twelve months, Blue Sail Medical Co generated revenue of 5.8B CNY at a net margin of -14.4%. Revenue grew 6.3% year over year. It earns a return on equity of -8.8%. Net debt stands at 1.2B CNY. Fundamentals as of Jul 22, 2026
Our scenario range runs from ¥3.01 (bear case) to ¥5.82 (bull case); at ¥5.68, the current price sits within that range. The share trades about 36% below its 52-week high and 10% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -32% fair-value upside, at -22%, 002382 screens cheaper than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 22, 2026. TTM = trailing twelve months.
About the company
Blue Sail Medical Co.,Ltd. operates as a medical device company in China and internationally. It operates through Health Protection Division; Cardiovascular and Cerebrovascular Department; and Emergency Rescue Division segments. The company offers cardiovascular and cerebrovascular products comprising drug-eluting stents and balloons, conventional balloons, and transcatheter aortic valve replacement systems; and disposable health protection gloves consisting of disposable nitrile, PVC, latex, and TPE/CPE gloves, as well as polyurethane gloves for use in medical examinations, food processing, industrial labor protection, daily protection, and other applications. It also provides emergency rescue products, such as road rescue kits, Red Cross foreign aid kits, AED family emergency kits, Firstaid series, mother's parcels, pet and catering first aid kits, portable protection and AED emergency kits, road rescue and fire emergency kits, AED first aid kits, eye wash first aid kits, face …
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Blue Sail Medical Co reported revenue of ¥5.7B in FY2025 versus ¥8.1B in FY2021, a compound −8.3%/yr. Reported net income was −¥759M in FY2025.
Is 002382 fairly valued? → Check now
Similar stocks
10 more Medical Instruments & Supplies stocks, each showing price versus our Fair Value estimate (as of Jul 22, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Intuitive Surgical, Inc ISRG | C$20.93 | C$10.43 | -50% |
| EssilorLuxottica Société anonyme ESLOF | $190.25 | $125.65 | -34% |
| Medline Inc MDLN | $34.71 | $30.15 | -13% |
| HOYA Corporation HOCPY | $168.16 | $96.16 | -43% |
| Becton, Dickinson and Company BDX | $147.79 | $124.26 | -16% |
| Alcon Inc ALC | $65.18 | $44.21 | -32% |
| ResMed Inc RMD | $196.04 | $185.14 | -6% |
| West Pharmaceutical Services, Inc WST | $330.92 | $114.00 | -66% |
| Terumo Corporation TRUMF | $14.62 | $12.65 | -13% |
| Straumann Holding SAUHY | $12.68 | $5.49 | -57% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Blue Sail Medical Co (002382) undervalued?
What is the fair value of 002382?
What is the quality score of 002382?
What is the revenue of Blue Sail Medical Co (002382)?
What is the net profit margin of 002382?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Unlock the full Blue Sail Medical Co analysis, and try Pro free
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.